COVID-19 Records

For review by noon Monday 7/15: Review draft NIAID TA on Risky Research Review Act

Reading Room Production, pp.154-155 · reading_room:email:00153

Page text: p.154, p.155 · original PDF

Date
2024-07-15 10:35
Type
email · email
cc
Emily Erbelding, Steven Holland, Christopher Hanson, Kelly Poe, Sharon Gilles, Ddsm Correspondences
sender
Sara Selgrade
to
Robert Eiss, Michael Nealy, Hugh Auchincloss, Jill Harper, Marie Parker, Courtney Billet
Topics
Proximal Origin paper

This text appears inside a quoted reply chain — it is evidence that the message was circulating, not necessarily a new message.

This is a duplicate copy. Canonical version: reading_room:email:00127

Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara ol D) () PM AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii a NIH/NIAID) [E] VIH/NIAID) [E] iy >; || (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] has asked us to ze We will be sure Please let me know if you have any questions. ) 1AM [AID DEA DART ID DIR-OCGR < NIH/NIAID) [E] )() ay P| >; Billet,

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

  1. 2024-07-15 10:35 Sara Selgrade open
    Hello all, ol In the attached revised draft, I jections, I will submit these to D) (e)] PM AID DEA DART NIAID) [E] i \IH/NIAID) [E] ii || NIH/NIAID) [E] NIAID) [E] VIH/NIAID) [E] iy >; || (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] has asked us to ze We will be sure Please let me know if you have any questions. () 1AM [AID DEA DART ID DIR-OCGR < VIH/NIAID) [--] i I Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara
  2. 2024-07-15 10:35 Sara Selgrade open
    Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara
  3. 2024-07-15 10:35 Sara Selgrade open
    Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara
  4. 2024-07-15 10:35 Sara Selgrade open
    Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara
  5. 2024-07-15 10:35 Sara Selgrade
    Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara ol D) () PM AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii a NIH/NIAID) [E] VIH/NIAID) [E] iy >; || (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] has asked us to ze We will be sure Please let me know if you have any questions. ) 1AM [AID DEA DART ID DIR-OCGR < NIH/NIAID) [E] )() ay P| >; Billet,
  6. 2024-07-15 10:35 Sara Selgrade open
    Hello all, Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to NIH OLPA by their noon deadline today. I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS. Please let me know if you have any questions or concerns. Thanks, Sara

Full conversation →